This model is consistent with our findings that progression of Dnmt3a-mutant CH to Dnmt3a- and Npm1-mutant AML is accompanied by a depletion of the expanded pool of HSCs observed in CH and a shift towards an expanded pool of myeloid-restricted progenitors that possess LSC activity. This evidence concerns the gene NPM1 and acute myeloid leukemia.